Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS).
Publication
, Conference
Eteshola, EOU; Landa, K; Hwang, ES; Moreno, A; Nair, SK; Sullenger, BA
Published in: CANCER IMMUNOLOGY RESEARCH
March 1, 2020
Duke Scholars
Published In
CANCER IMMUNOLOGY RESEARCH
EISSN
2326-6074
ISSN
2326-6066
Publication Date
March 1, 2020
Volume
8
Issue
3
Start / End Page
76 / 76
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Eteshola, E. O. U., Landa, K., Hwang, E. S., Moreno, A., Nair, S. K., & Sullenger, B. A. (2020). Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS). In CANCER IMMUNOLOGY RESEARCH (Vol. 8, pp. 76–76). AMER ASSOC CANCER RESEARCH.
Eteshola, Elias O. U., Karenia Landa, E Shelley Hwang, Angelo Moreno, Smita K. Nair, and Bruce A. Sullenger. “Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS).” In CANCER IMMUNOLOGY RESEARCH, 8:76–76. AMER ASSOC CANCER RESEARCH, 2020.
Eteshola EOU, Landa K, Hwang ES, Moreno A, Nair SK, Sullenger BA. Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS). In: CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH; 2020. p. 76–76.
Eteshola, Elias O. U., et al. “Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS).” CANCER IMMUNOLOGY RESEARCH, vol. 8, no. 3, AMER ASSOC CANCER RESEARCH, 2020, pp. 76–76.
Eteshola EOU, Landa K, Hwang ES, Moreno A, Nair SK, Sullenger BA. Blocking proinvasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NAS). CANCER IMMUNOLOGY RESEARCH. AMER ASSOC CANCER RESEARCH; 2020. p. 76–76.
Published In
CANCER IMMUNOLOGY RESEARCH
EISSN
2326-6074
ISSN
2326-6066
Publication Date
March 1, 2020
Volume
8
Issue
3
Start / End Page
76 / 76
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology